GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » COGS-to-Revenue

Nanjing Medlander Medical Technology Co (SHSE:688273) COGS-to-Revenue : 0.26 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nanjing Medlander Medical Technology Co COGS-to-Revenue?

Nanjing Medlander Medical Technology Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥27.1 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥104.3 Mil.

Nanjing Medlander Medical Technology Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.26.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Nanjing Medlander Medical Technology Co's Gross Margin % for the three months ended in Mar. 2024 was 74.05%.

Nanjing Medlander Medical Technology Co COGS-to-Revenue Historical Data

The historical data trend for Nanjing Medlander Medical Technology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Medlander Medical Technology Co COGS-to-Revenue Chart

Nanjing Medlander Medical Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.20 0.24 0.27 0.31 0.29

Nanjing Medlander Medical Technology Co Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.26 0.24 0.26 0.26

Nanjing Medlander Medical Technology Co COGS-to-Revenue Calculation

Nanjing Medlander Medical Technology Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=98.466 / 340.825
=0.29

Nanjing Medlander Medical Technology Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=27.071 / 104.337
=0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanjing Medlander Medical Technology Co  (SHSE:688273) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Nanjing Medlander Medical Technology Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 27.071 / 104.337
=74.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Nanjing Medlander Medical Technology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanjing Medlander Medical Technology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Medlander Medical Technology Co (SHSE:688273) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Medlander Medical Technology Co Ltd (SHSE:688273) » Definitions » COGS-to-Revenue
Comparable Companies
SZSE:301290 SZSE:301515 SHSE:688613 SZSE:300289 SZSE:300642 SHSE:688338 SZSE:300246 SZSE:301033 SZSE:300813 SZSE:301235 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 2, Gande Road, 2nd Floor, Building 5, Jiangning High-tech Park, Jiangning District, Jiangsu Province, Nanjing City, CHN, 211100
Website
http://www.medlander.com
Nanjing Medlander Medical Technology Co Ltd is engaged in the research and development, production, sales and service of related products in the field of pelvic floor and postpartum rehabilitation.
Executives
Zhu Bi Sheng senior management
Chen Jiang Ning senior management
Yang Rui Jia Directors, senior managers, core technical personn
Shi Zhi Huai Directors, senior managers, core technical personn
Chen Bin Directors, senior managers
Tu Hong Lin Directors, senior managers
Wang Wang senior management

Nanjing Medlander Medical Technology Co (SHSE:688273) Headlines

No Headlines